124 related articles for article (PubMed ID: 23545938)
1. RIP1 expression is necessary for CD30-mediated cell death induction in anaplastic large-cell lymphoma cells.
Hirsch B; von der Wall E; Hummel M; Dürkop H
Lab Invest; 2013 Jun; 93(6):677-89. PubMed ID: 23545938
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of p38 mitogen-activated protein kinase unmasks a CD30-triggered apoptotic pathway in anaplastic large cell lymphoma cells.
Krysov SV; Rowley TF; Al-Shamkhani A
Mol Cancer Ther; 2007 Feb; 6(2):703-11. PubMed ID: 17308066
[TBL] [Abstract][Full Text] [Related]
3. Death receptor apoptosis signaling mediated by FADD in CD30-positive lymphoproliferative disorders involving the skin.
Clarke LE; Bayerl MG; Bruggeman RD; Mauger D; Ioffreda MD; Abou-Elella A; Helm KF
Am J Surg Pathol; 2005 Apr; 29(4):452-9. PubMed ID: 15767797
[TBL] [Abstract][Full Text] [Related]
4. Cellular IAP proteins and LUBAC differentially regulate necrosome-associated RIP1 ubiquitination.
de Almagro MC; Goncharov T; Newton K; Vucic D
Cell Death Dis; 2015 Jun; 6(6):e1800. PubMed ID: 26111062
[TBL] [Abstract][Full Text] [Related]
5. Galectin-1-mediated cell death is increased by CD30-induced signaling in anaplastic large cell lymphoma cells but not in Hodgkin lymphoma cells.
Suzuki O; Hirsch B; Abe M; Dürkop H; Stein H
Lab Invest; 2012 Feb; 92(2):191-9. PubMed ID: 21986812
[TBL] [Abstract][Full Text] [Related]
6. TWEAK induces apoptosis through a death-signaling complex comprising receptor-interacting protein 1 (RIP1), Fas-associated death domain (FADD), and caspase-8.
Ikner A; Ashkenazi A
J Biol Chem; 2011 Jun; 286(24):21546-54. PubMed ID: 21525013
[TBL] [Abstract][Full Text] [Related]
7. RIP1 protein-dependent assembly of a cytosolic cell death complex is required for inhibitor of apoptosis (IAP) inhibitor-mediated sensitization to lexatumumab-induced apoptosis.
Basit F; Humphreys R; Fulda S
J Biol Chem; 2012 Nov; 287(46):38767-77. PubMed ID: 22927431
[TBL] [Abstract][Full Text] [Related]
8. CD30 activates both the canonical and alternative NF-kappaB pathways in anaplastic large cell lymphoma cells.
Wright CW; Rumble JM; Duckett CS
J Biol Chem; 2007 Apr; 282(14):10252-62. PubMed ID: 17261581
[TBL] [Abstract][Full Text] [Related]
9. Distinct motifs in the intracellular domain of human CD30 differentially activate canonical and alternative transcription factor NF-κB signaling.
Buchan SL; Al-Shamkhani A
PLoS One; 2012; 7(9):e45244. PubMed ID: 23028875
[TBL] [Abstract][Full Text] [Related]
10. RIP1-dependent and independent effects of necrostatin-1 in necrosis and T cell activation.
Cho Y; McQuade T; Zhang H; Zhang J; Chan FK
PLoS One; 2011; 6(8):e23209. PubMed ID: 21853090
[TBL] [Abstract][Full Text] [Related]
11. Differential expression and function of A20 and TRAF1 in Hodgkin lymphoma and anaplastic large cell lymphoma and their induction by CD30 stimulation.
Dürkop H; Hirsch B; Hahn C; Foss HD; Stein H
J Pathol; 2003 Jun; 200(2):229-39. PubMed ID: 12754742
[TBL] [Abstract][Full Text] [Related]
12. Intermediate domain of receptor-interacting protein kinase 1 (RIPK1) determines switch between necroptosis and RIPK1 kinase-dependent apoptosis.
Duprez L; Bertrand MJ; Vanden Berghe T; Dondelinger Y; Festjens N; Vandenabeele P
J Biol Chem; 2012 Apr; 287(18):14863-72. PubMed ID: 22362767
[TBL] [Abstract][Full Text] [Related]
13. A JNK-mediated autophagy pathway that triggers c-IAP degradation and necroptosis for anticancer chemotherapy.
He W; Wang Q; Srinivasan B; Xu J; Padilla MT; Li Z; Wang X; Liu Y; Gou X; Shen HM; Xing C; Lin Y
Oncogene; 2014 Jun; 33(23):3004-13. PubMed ID: 23831571
[TBL] [Abstract][Full Text] [Related]
14. The tyrosine kinase NPM-ALK, associated with anaplastic large cell lymphoma, binds the intracellular domain of the surface receptor CD30 but is not activated by CD30 stimulation.
Hübinger G; Scheffrahn I; Müller E; Bai R; Duyster J; Morris SW; Schrezenmeier H; Bergmann L
Exp Hematol; 1999 Dec; 27(12):1796-805. PubMed ID: 10641597
[TBL] [Abstract][Full Text] [Related]
15. Autocrine growth regulation of CD30 ligand in CD30-expressing Reed-Sternberg cells: distinction between Hodgkin's disease and anaplastic large cell lymphoma.
Hsu PL; Hsu SM
Lab Invest; 2000 Jul; 80(7):1111-9. PubMed ID: 10908157
[TBL] [Abstract][Full Text] [Related]
16. cIAP1 and cIAP2 limit macrophage necroptosis by inhibiting Rip1 and Rip3 activation.
McComb S; Cheung HH; Korneluk RG; Wang S; Krishnan L; Sad S
Cell Death Differ; 2012 Nov; 19(11):1791-801. PubMed ID: 22576661
[TBL] [Abstract][Full Text] [Related]
17. The NPM-ALK oncoprotein abrogates CD30 signaling and constitutive NF-kappaB activation in anaplastic large cell lymphoma.
Horie R; Watanabe M; Ishida T; Koiwa T; Aizawa S; Itoh K; Higashihara M; Kadin ME; Watanabe T
Cancer Cell; 2004 Apr; 5(4):353-64. PubMed ID: 15093542
[TBL] [Abstract][Full Text] [Related]
18. CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells.
Hirsch B; Hummel M; Bentink S; Fouladi F; Spang R; Zollinger R; Stein H; Dürkop H
Am J Pathol; 2008 Feb; 172(2):510-20. PubMed ID: 18187570
[TBL] [Abstract][Full Text] [Related]
19. RIPK1 and TRADD Regulate TNF-Induced Signaling and Ripoptosome Formation.
Feoktistova M; Makarov R; Yazdi AS; Panayotova-Dimitrova D
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830347
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of caspases primes colon cancer cells for 5-fluorouracil-induced TNF-α-dependent necroptosis driven by RIP1 kinase and NF-κB.
Oliver Metzig M; Fuchs D; Tagscherer KE; Gröne HJ; Schirmacher P; Roth W
Oncogene; 2016 Jun; 35(26):3399-409. PubMed ID: 26522725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
